AngioDynamics, Inc.
ANGO Real Time Price USDRecent trades of ANGO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ANGO's directors and management
Government lobbying spending instances
-
$45,000 Jul 13, 2010 Issue: Health Issues
-
$18,000 Jul 20, 2009 Issue: Health Issues
-
$45,000 Apr 20, 2009 Issue: Health Issues
-
$36,000 Jan 20, 2009 Issue: Health Issues
-
$20,250 Oct 17, 2008 Issue: Health Issues
-
$16,875 Jul 18, 2008 Issue: Health Issues
-
$33,750 Apr 11, 2008 Issue: Health Issues
-
$70,000 Feb 04, 2008 Issue: Medical/Disease Research/Clinical Labs
-
$70,000 Aug 06, 2007 Issue: Medical/Disease Research/Clinical Labs
-
$20,000 Jan 18, 2007 Issue: Medical/Disease Research/Clinical Labs
-
$25,000 Aug 01, 2006 Issue: Medicare/Medicaid Medical/Disease Research/Clinical Labs
-
$25,000 Jan 31, 2006 Issue: Health Issues
Estimated quarterly lobbying spending
ANGO Revenue by Segment or Geography
No Revenue by Segment data for this ticker
No Revenue by Geography data for this ticker
New patents grants
Federal grants, loans, and purchases
- $75,000 2025-01-24 00:00:00 Agency: Department of Veterans Affairs
- $25,125 2024-09-27 00:00:00 Agency: Department of Veterans Affairs
- $16,320 2024-04-26 00:00:00 Agency: Department of Health and Human Services
- $24,000 2024-04-16 00:00:00 Agency: Department of Veterans Affairs
- $25,125 2023-06-08 00:00:00 Agency: Department of Veterans Affairs
- $21,000 2023-04-25 00:00:00 Agency: Department of Health and Human Services
- $400,000 2022-08-24 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $90,133 2022-05-19 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $31,571 2022-05-05 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $2,213 2022-04-22 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $104,000 2022-03-10 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $14,500 2022-01-31 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $2,213 2022-01-25 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $36,000 2021-12-21 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $74,000 2021-12-16 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $6,106 2021-12-13 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $28,200 2021-11-03 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $29,000 2021-10-07 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $65,000 2021-09-17 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $2,434 2021-09-07 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $22,000 2021-08-17 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $14,650 2021-06-25 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $89,298 2021-04-08 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
- $9,999 2021-02-04 00:00:00 Agency: DEPARTMENT OF DEFENSE (DOD)
Estimated quarterly amount awarded from public contracts
Recent insights relating to ANGO
Number of mentions of ANGO in WallStreetBets Daily Discussion
Recent picks made for ANGO stock on CNBC
ETFs with the largest estimated holdings in ANGO
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ANGO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.